Smart science to improve lives™

Explore our latest available downloads...

Explore Croda Pharmas resource area

Excipients in parenteral drug delivery - Injectable delivery of Small Molecules

Discover our latest literature highlighting our high purity excipients used in the parenteral delivery of small molecule drugs. Included in our latest brochure are our lipid offerings.

Lipids play a pivotal role in enhancing the parenteral delivery of small molecule APIs by facilitating the formation of liposomes while Liposomes provide a stable and biocompatible carrier system for the encapsulation and solubilization of both hydrophobic and hydrophilic drug compounds.

This unique capability not only improves the drug's bioavailability but also ensures a controlled and sustained release, optimising therapeutic outcomes. Liposomal drug delivery has shown proven efficacy in various small molecule applications, including: pain management drugs, cancer therapies and more...

The ability of liposomes to encapsulate drugs makes them an ideal choice for targeted delivery, addressing the specific challenges associated with these critical therapeutic areas. Our commitment to advancing cutting edge science supports the development of medicines, empowering formulators with reliable solutions for developing next-generation therapies

Injectable delivery of small molecules flyer

Croda Pharma flyer - Injectables for small molecules
288.3 KB

Vaccines for a more sustainable future whitepaper

Confronting the challenge and impact of climate change is all around us and it's equally important that this is considered when in the development of novel vaccines. If we continually tap into nature’s resources in an unsustainable way, we will inevitably run out.
We can all contribute to not only select sustainable ingredients, but to secure supply chains and sources that will not deplete in the future. We discuss this in our latest white paper: Vaccines for a more sustainable future.

We must take every possible step to safeguard our planet as we strive for a sustainable future. A nature-positive approach empowers our planet and communities. It's a revolutionary concept that challenges us to reimagine our role on Earth, by acting to positively impact biodiversity and the natural environment.
Yet, confronting this challenge isn't limited to only addressing climate issues; we must extend our efforts to embrace and protect nature as well.

EXCLUSIVE WHITEPAPER: Vaccines for a more sustainable future

Download Croda Pharmas new whitepaper, Vaccines for a sustainable future
335.1 KB

Explore recent blogs:

Sohnke Voss PhD, Croda Pharma

Lipid Leaders: Söhnke Voss

In this Lipid Leaders interview, we speak to Söhnke Voss, PhD. Söhnke is a lipids expert with over 25 years’ experience in the pharmaceutical industry. Keep reading to learn more about lipids and the...

Read more

Croda Pharma wins ‘Best Production/Process Development’ Award at the 17th annual Vaccine Industry Excellence awards

Croda Pharma has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived...

Read more
lab image

Partnership agreement between Croda and AAHI to drive innovation in vaccine development

19 March 2024: Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development...

Read more
child being vaccinated

Croda Foundation announces it has sustainably improved the lives of 22.8 million people – exceeding its 2030 target.

Croda Foundation announces it has sustainably improved the lives of 22.8 million people –exceeding its 2030 target.

Read more